“…Two related issues touched on in these articles could benefit from further exploration, including accreditation's role in increasing public availability of information and how quality assurance information is used, or not used, to evaluate institutions for the purpose of gatekeeping of international medical graduates (IMGs) throughout the world. Many accreditation systems and the WFME Recognition Program strive, albeit with some limited success, [5][6][7] to increase the amount and public availability of information on educational institutions so students can make informed choices. Just as the United States is only one of two countries (the other being New Zealand) that allow pharmaceutical companies to advertise regulated drugs directly to consumers, the medical education field in this country is encumbered by commercials for educational institutions with potentially misleading or incomplete information on the quality of education delivered, student success, and practice opportunities for physician graduates.…”